The gene expression levels of tumor suppression genes (BRCA1, BRCA2, and p53), oncogenes (HER1, HER2, and cMyc), cell cycle genes (CCND1, WNT3A, MAPK1, and MAPK3), and apoptosis genes (BCL2, MCL1, DAPK1, Casp8, and Casp9) were quantified 48-h post treatment; the results are demonstrated in Figure 8 and Figure 9. This evidence concerns the gene BRCA2 and neoplasm.